Conestoga Capital Advisors LLC Has $246,000 Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Conestoga Capital Advisors LLC continued to hold its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,795 shares of the medical instruments supplier’s stock at the end of the second quarter. Conestoga Capital Advisors LLC’s holdings in DENTSPLY SIRONA were worth $246,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of XRAY. BlackRock Inc. boosted its position in DENTSPLY SIRONA by 3,103.7% in the first quarter. BlackRock Inc. now owns 13,891,329 shares of the medical instruments supplier’s stock worth $867,376,000 after buying an additional 13,457,730 shares during the period. Principal Financial Group Inc. boosted its position in DENTSPLY SIRONA by 1,445.2% in the first quarter. Principal Financial Group Inc. now owns 5,292,885 shares of the medical instruments supplier’s stock worth $330,488,000 after buying an additional 4,950,337 shares during the period. Clearbridge Investments LLC boosted its position in DENTSPLY SIRONA by 34.6% in the first quarter. Clearbridge Investments LLC now owns 5,258,060 shares of the medical instruments supplier’s stock worth $328,313,000 after buying an additional 1,353,040 shares during the period. Point72 Asset Management L.P. purchased a new position in DENTSPLY SIRONA during the first quarter worth $64,184,000. Finally, Renaissance Technologies LLC boosted its position in DENTSPLY SIRONA by 246.0% in the first quarter. Renaissance Technologies LLC now owns 1,044,558 shares of the medical instruments supplier’s stock worth $65,222,000 after buying an additional 742,700 shares during the period. 95.13% of the stock is owned by hedge funds and other institutional investors.

Shares of DENTSPLY SIRONA Inc. (XRAY) traded down 0.60% during midday trading on Friday, hitting $52.85. 1,573,864 shares of the stock traded hands. The company’s market cap is $12.13 billion. The stock has a 50-day moving average of $61.35 and a 200-day moving average of $62.19. DENTSPLY SIRONA Inc. has a 52-week low of $52.73 and a 52-week high of $65.68.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.65. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The business had revenue of $992.70 million during the quarter, compared to the consensus estimate of $1 billion. During the same quarter last year, the company earned $0.76 earnings per share. The business’s quarterly revenue was down 2.9% compared to the same quarter last year. On average, equities analysts predict that DENTSPLY SIRONA Inc. will post $2.69 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, October 13th. Stockholders of record on Friday, September 29th will be given a dividend of $0.0875 per share. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.66%. The ex-dividend date of this dividend is Thursday, September 28th. DENTSPLY SIRONA’s payout ratio is currently -10.09%.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by BNB Daily and is owned by of BNB Daily. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright laws. The original version of this piece of content can be read at https://www.baseball-news-blog.com/2017/08/19/dentsply-sirona-inc-nasdaqxray-position-maintained-by-conestoga-capital-advisors-llc-updated-updated-updated.html.

Several analysts have commented on the stock. HC Wainwright reiterated a “buy” rating and issued a $68.00 price target (down previously from $74.00) on shares of DENTSPLY SIRONA in a research note on Monday. Credit Suisse Group reiterated an “outperform” rating and issued a $75.00 price target (up previously from $67.00) on shares of DENTSPLY SIRONA in a research note on Thursday, July 13th. BidaskClub upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Friday, June 30th. TheStreet cut shares of DENTSPLY SIRONA from a “b” rating to a “c+” rating in a research report on Wednesday, August 9th. Finally, Morgan Stanley upped their target price on shares of DENTSPLY SIRONA from $66.00 to $67.00 and gave the company an “overweight” rating in a research report on Thursday, August 10th. Three equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and eight have given a buy rating to the company. The stock currently has an average rating of “Hold” and an average target price of $66.25.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply